SSII vs AEYE vs ISRG vs ALKT vs SYK

For growth investors, SS Innovations International, Inc.

(SSII) is the stronger pick with 105. 7% revenue growth year-over-year, versus 11. 2% for Stryker Corporation (SYK). Stryker Corporation (SYK) offers the better valuation at 35. 0x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Intuitive Surgical, Inc. (ISRG) a "Buy" — based on 55 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Stryker Corporation (SYK) is the cheapest at 35.

0x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Stryker Corporation is actually cheaper at 19. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Stryker Corporation wins at 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x — a reasonable growth-adjusted valuation.

Over the past 5 years, SS Innovations International, Inc.

(SSII) delivered a total return of +281. 6%, compared to -60. 2% for AudioEye, Inc. (AEYE). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus ALKT's -58. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), SS Innovations International, Inc.

(SSII) is the lower-risk stock at 0. 04β versus AudioEye, Inc. 's 2. 18β — meaning AEYE is approximately 5220% more volatile than SSII relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 98% for Alkami Technology, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), SS Innovations International, Inc.

(SSII) is pulling ahead at 105. 7% versus 11. 2% for Stryker Corporation (SYK). On earnings-per-share growth, the picture is similar: SS Innovations International, Inc. grew EPS 40. 0% year-over-year, compared to -12. 2% for Alkami Technology, Inc.. Over a 3-year CAGR, SSII leads at 207. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -28. 5% for SS Innovations International, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -19. 2% for SSII. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Stryker Corporation (SYK) is the more undervalued stock at a PEG of 1. 28x versus Intuitive Surgical, Inc. 's 1. 99x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Stryker Corporation (SYK) trades at 19. 1x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 24. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 3% to $622. 60.

In this comparison, SYK (1.

1% yield) pays a dividend. SSII, AEYE, ISRG, ALKT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

52), 1. 1% yield, +179. 2% 10Y return). AudioEye, Inc. (AEYE) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SYK: +179. 2%, AEYE: +96. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SSII (Healthcare) and AEYE (Technology) and ISRG (Healthcare) and ALKT (Technology) and SYK (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SSII is a small-cap high-growth stock; AEYE is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; ALKT is a small-cap high-growth stock; SYK is a mid-cap quality compounder stock. SYK pays a dividend while SSII, AEYE, ISRG, ALKT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.